Literature DB >> 16246969

Molecular regulation of platelet-dependent thrombosis.

Jane E Freedman1.   

Abstract

Hemostasis is a normal process preventing the sequelae of uncontrolled hemorrhage. In certain settings, these same processes cause adverse clinical events due to thrombotic occlusion of a vessel. The majority of unstable coronary syndromes result from disruption of an atherosclerotic plaque, leading to the exposure of subintimal contents, which triggers coagulation and the formation of a platelet-rich thrombus. The central role of platelet activation in the events that lead to vessel occlusion is well known. However, this process is complex and influenced by a myriad of cellular and plasma-derived mediators that regulate the balance between occlusive and nonocclusive thrombosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16246969     DOI: 10.1161/CIRCULATIONAHA.104.494468

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  21 in total

Review 1.  Platelets from genome to proteome and beyond.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2007-06       Impact factor: 2.300

Review 2.  Signal-dependent protein synthesis by activated platelets: new pathways to altered phenotype and function.

Authors:  Guy A Zimmerman; Andrew S Weyrich
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-03       Impact factor: 8.311

Review 3.  Platelet reactivity and the identification of acute coronary syndromes in the emergency department.

Authors:  Chad E Darling; Alan D Michelson; Gregory A Volturo; Karin Przyklenk
Journal:  J Thromb Thrombolysis       Date:  2008-07-04       Impact factor: 2.300

4.  Ectonucleotide triphosphate diphosphohydrolase-1 (CD39) mediates resistance to occlusive arterial thrombus formation after vascular injury in mice.

Authors:  Zachary M Huttinger; Michael W Milks; Michael S Nickoli; William L Aurand; Lawrence C Long; Debra G Wheeler; Karen M Dwyer; Anthony J F d'Apice; Simon C Robson; Peter J Cowan; Richard J Gumina
Journal:  Am J Pathol       Date:  2012-05-18       Impact factor: 4.307

Review 5.  Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum.

Authors:  Adriana Vieira-de-Abreu; Robert A Campbell; Andrew S Weyrich; Guy A Zimmerman
Journal:  Semin Immunopathol       Date:  2011-08-06       Impact factor: 9.623

6.  NP-184[2-(5-methyl-2-furyl) benzimidazole], a novel orally active antithrombotic agent with dual antiplatelet and anticoagulant activities.

Authors:  Heng-Lan Kuo; Jin-Cherng Lien; Ching-Hu Chung; Chien-Hsin Chang; Shyh-Chyi Lo; I-Chun Tsai; Hui-Chin Peng; Sheng-Chu Kuo; Tur-Fu Huang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-03-27       Impact factor: 3.000

7.  Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.

Authors:  Roman Covarrubias; Elena Chepurko; Adam Reynolds; Zachary M Huttinger; Ryan Huttinger; Katherine Stanfill; Debra G Wheeler; Tatiana Novitskaya; Simon C Robson; Karen M Dwyer; Peter J Cowan; Richard J Gumina
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-07-14       Impact factor: 8.311

8.  Artificial niche combining elastomeric substrate and platelets guides vascular differentiation of bone marrow mononuclear cells.

Authors:  Wei Wu; Robert Allen; Jin Gao; Yadong Wang
Journal:  Tissue Eng Part A       Date:  2011-05-12       Impact factor: 3.845

9.  NP-313, 2-acetylamino-3-chloro-1,4-naphthoquinone, a novel antithrombotic agent with dual inhibition of thromboxane A(2) synthesis and calcium entry.

Authors:  Heng-Lan Kuo; Jin-Cherng Lien; Chien-Hsin Chang; Ching-Hu Chung; Sheng-Chu Kuo; Chun-Chieh Hsu; Hui-Chin Peng; Tur-Fu Huang
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

Review 10.  Platelets as cellular effectors of inflammation in vascular diseases.

Authors:  Matthew T Rondina; Andrew S Weyrich; Guy A Zimmerman
Journal:  Circ Res       Date:  2013-05-24       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.